Cord Blood America, Inc. (CBAI.OB) Reduces an Additional $817,000 in Long-Term Debt
Cord Blood America, Inc., an umbilical cord blood stem cell preservation company, announced today that it has eliminated $817,000 of long-term debt in addition to the recently announced long-term debt elimination of $1.75 million. Matthew Schissler, Cord Blood America Founder and CEO, commented, "The remaining debt with YA Global Investments, formerly Cornell Capital Partners, has been assigned to an existing institutional investor. CBAI and YA Global Investments agreed on a one time common share settlement for liquidated damages in connection with assigning the outstanding principal and interest to the existing investor. With this assignment, CBAI has no further debt with…